Literature DB >> 22362601

Cell cycle-related kinase links androgen receptor and β-catenin signaling in hepatocellular carcinoma: why are men at a loss?

Prince K Awuah1, Satdarshan P Monga.   

Abstract

Entities:  

Year:  2012        PMID： 22362601      PMCID： PMC3545276          DOI： 10.1002/hep.24774

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  21 in total

1.  Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.

Authors:  Xu-Feng Zhang; Xinping Tan; Gang Zeng; Amalea Misse; Sucha Singh; Youngsoo Kim; James E Klaunig; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 2.  WNT/beta-catenin signaling in liver health and disease.

Authors:  Michael D Thompson; Satdarshan P S Monga
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

3.  Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.

Authors:  Benjamin Rignall; Albert Braeuning; Albrecht Buchmann; Michael Schwarz
Journal:  Carcinogenesis       Date:  2010-11-03       Impact factor: 4.944

4.  Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.

Authors:  Kari N Nejak-Bowen; Michael D Thompson; Sucha Singh; William C Bowen; Mohd Jamal Dar; Jaspal Khillan; Chunsun Dai; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

Authors:  Ming-Heng Wu; Wen-Lung Ma; Cheng-Lung Hsu; Yuh-Ling Chen; Jing-Hsiung James Ou; Charlotte Kathryn Ryan; Yao-Ching Hung; Shuyuan Yeh; Chawnshang Chang
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

6.  Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.

Authors:  J Zucman-Rossi; S Benhamouche; C Godard; S Boyault; G Grimber; C Balabaud; A S Cunha; P Bioulac-Sage; C Perret
Journal:  Oncogene       Date:  2006-09-11       Impact factor: 9.867

7.  CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.

Authors:  Vicki Gordon; Shriti Bhadel; Winfried Wunderlich; JoAnn Zhang; Scott B Ficarro; Sahana A Mollah; Jeffrey Shabanowitz; Donald F Hunt; Ioannis Xenarios; William C Hahn; Mark Conaway; Michael F Carey; Daniel Gioeli
Journal:  Mol Endocrinol       Date:  2010-10-27

8.  Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.

Authors:  Gang Wang; Jun Wang; Marianne D Sadar
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

9.  CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.

Authors:  Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

10.  Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.

Authors:  Wen-Lung Ma; Cheng-Lung Ma; Cheng-Lung Hsu; Ming-Heng Wu; Chun-Te Wu; Cheng-Chia Wu; Jiann-Jyh Lai; Yuh-Shan Jou; Chun-Wei Chen; Shuyuan Yeh; Chawnshang Chang
Journal:  Gastroenterology       Date:  2008-05-22       Impact factor: 22.682
View more
  7 in total

1.  Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.

Authors:  Jingying Zhou; Man Liu; Hanyong Sun; Yu Feng; Liangliang Xu; Anthony W H Chan; Joanna H Tong; John Wong; Charing Ching Ning Chong; Paul B S Lai; Hector Kwong-Sang Wang; Shun-Wa Tsang; Tyler Goodwin; Rihe Liu; Leaf Huang; Zhiwei Chen; Joseph Jy Sung; King Lau Chow; Ka Fai To; Alfred Sze-Lok Cheng
Journal:  Gut       Date:  2017-09-22       Impact factor: 23.059

2.  Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.

Authors:  Danyang Liu; Yonglong Zhang; Yingze Wei; Guoyuan Liu; Yufeng Liu; Qiongmei Gao; Liping Zou; Wenjiao Zeng; Nong Zhang
Journal:  Oncotarget       Date:  2016-10-04

3.  CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.

Authors:  Zhi-Qiang Li; Wei-Ru Wu; Chen Zhao; Chen Zhao; Xiao-Li Zhang; Zhong Yang; Jing Pan; Wei-Ke Si
Journal:  Int J Mol Med       Date:  2017-12-29       Impact factor: 4.101

4.  Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma.

Authors:  Xinhuang Chen; Yan Liao; Yaqun Yu; Pengpeng Zhu; Jun Li; Liling Qin; Weijia Liao; Zhaoquan Huang
Journal:  Oncotarget       Date:  2017-10-04

Review 5.  Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.

Authors:  Ozlem Kutlu; Humeyra Nur Kaleli; Ebru Ozer
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-29

Review 6.  The Role of Cell Cycle Regulators in Cell Survival-Dual Functions of Cyclin-Dependent Kinase 20 and p21Cip1/Waf1.

Authors:  Lo Lai; Ga Yoon Shin; Hongyu Qiu
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

Review 7.  Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.

Authors:  Daryl Ramai; Antonio Facciorusso; Erika Vigandt; Bryan Schaf; Waleed Saadedeen; Aditya Chauhan; Sara di Nunzio; Aashni Shah; Luca Giacomelli; Rodolfo Sacco
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.